WHO approves Bavarian Nordic’s mpox vaccine for adolescents

World Health Organization (WHO) has approved Bavarian Nordic's mpox vaccine (Jynneos) for adolescents aged 12 to 17 years.

Vaccine Name: The vaccine is also known as IMVANEX.

Significance: This approval is crucial as adolescents are considered vulnerable to mpox outbreaks.

Global Health Emergency: The WHO declared mpox a global public health emergency for the second time in two years in August 2024 due to a new type of the virus spreading from the Democratic Republic of Congo to neighboring regions.